Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: a phase Ib study

Hu, Xingsheng; Cui, Xinge; Wang, Ziping; Liu, Yunpeng; Luo, Ying; Zhong, Wei; Zhao, Hui; Yao, Mengxing; Jiang, Da; Wang, Mingxia; Chen, Minjiang; Zheng, Xin; Ding, Lieming; Wang, Yang; Yuan, Xiaobin; Wu, Pengxiang; Hu, Bei; Han, Xiaohong; Shi, Yuankai

doi:10.1186/s12885-022-10500-y

BMC Cancer

Article metrics
Last updated: Mon, 6 May 2024 20:17:36 Z

Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: a phase Ib study

Access & Citations

1306

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com